Phase 1b study to assess the safety of neoadjuvant trifluridine/tipiracil with concurrent radiation in resectable stage II/III rectal cancer: Initial results of the FIERCE study.

Authors: Emerson Yu-sheng Chen, Nima Nabavizadeh, Daniel Herzig, Elena Korngold, Adel Kardosh, Guillaume Joe Pegna, Hagen Fritz Kennecke, Vassiliki Liana Tsikitis, Kim Lu, Sandy Fang, Flavio G. Rocha, Skye C. Mayo, Brian Brinkerhoff, Shaun M. Goodyear, Melissa Wong, Erin Taber, Christopher Lessenich, Brindha Rajagopalan, Charles R. Thomas, Charles D. Lopez,

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.3602

Source: Full article

---

Abstract

3602